Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anteris Technologies Global Corp. - Common Stock (NQ:AVR)

4.880 -0.080 (-1.61%)
Streaming Delayed Price Updated: 12:26 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Anteris Technologies Global Corp. - Common Stock

Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Top 2 Health Care Stocks That May Keep You Up At Night This Month
 
Via Benzinga
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Announces Results for the Second Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities 
From Anteris Technologies Global Corp.
Via GlobeNewswire
Here are the top movers in Tuesday's session.
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Anteris Announces Results for the First Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
New class, biomimetic TAVR demonstrates sustained hemodynamic performance to one-year 
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Reports 2024 Financial Results and Provides Corporate Update
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
From Anteris Technologies Global Corp.
Via GlobeNewswire
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030. 
Via Benzinga
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
 
Via Benzinga
INLIF, OneConstruction Group Make Public Debut
Both INLIF and OneConstruction Group opened for trading this week. The Chinese producer of industrial manipulator arms for injection molding raised $8 million, while the Hong Kong-based structural... 
Via Talk Markets
Topics Stocks / Equities
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
ServiceTitan Jumps 42% In Trading Debut
Shares of ServiceTitan jumped as much as 42% on Thursday when the cloud software vendor made its Nasdaq debut. ServiceTitan is the first significant tech company to go public since Rubrik's debut back... 
Via Talk Markets
Topics Stocks / Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.